STAT3 and osteosarcoma: After identifying CDDO-Me as an inhibitor of Stat3 nuclear translocation in osteosarcoma cells, the effect of CDDO-Me on Stat3 phosphorylation was examined in osteosarcoma drug sensitive and MDR cell lines.